NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amphasys

Amphasys

Private
RootFrontier & Industrial Techhttps://amphasys.com/

Company Overview

Amphasys is a biotechnology company that provides advanced solutions for high-precision, single-cell analysis using impedance flow cytometry for applications in the agriculture and bioprocessing industries.

Sector

Frontier & Industrial Tech

Verticals

Biotech Equipment, Quality Management, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

impedance flow cytometrylabel-free cell analysissingle-cell analysiscell viability analysismicrofluidic chipsbioprocess monitoringpollen analysisAgriTechprocess analytical technologyPATseed techplant breedingbiosensorbiotech equipmentrazor and blades modelfermentation monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amphasys Comparables

Compare Amphasys with similar companies based on industry and business-model similarity.

Amphasys comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SBT Instruments
83%
Yokogawa Electric Corporation
66%
Sysmex Corporation
62%

Amphasys Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Marco Di Berardino

CTO

Executive Team

Luca De Villa Palù

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 3, 2025

    Monthly visitors grew 60% MoM.

  • Jun 1, 2025

    Monthly visitors grew 403% MoM, reaching 1K.

Amphasys Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amphasys Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amphasys's valuation, stock price, and market status.

Firmographic Details

HeadquartersRoot
Employee Range26
Year Founded2012
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.